drugset

drugset / Trial / NCT03658291

Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection

NCT03658291 ↗

Phase 4 Unknown 252 enrolled China Academy of Chinese Medical Sciences Chengdu University of Traditional Chinese Medicine · collab Guangdong Provincial Hospital of Traditional Chinese Medicine · collab Hubei Hospital of Traditional Chinese Medicine · collab Shanghai University of Traditional Chinese Medicine · collab Xiyuan Hospital of China Academy of Chinese Medical Sciences · collab Yunnan Provinical Hospital of Traditional Chinese Medicine · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and immune mechanism of Sanjin tablets for the treatment of acute simple lower urinary tract infection and its influence on recurrence rate.

Timeline

Start: 2019-01-01
Primary completion: 2019-06-30
Completion: 2019-12-31

Publications

Lyu J, Xie YM, Gao Z, Shen JW, Deng YY, Xiang ST, Gao WX, Zeng WT, Zhang CH, Yi DH, Wang LX, Wang ZF. Sanjin tablets for acute uncomplicated lower urinary tract infection (syndrome of dampness-heat in the lower jiao): protocol for randomized, double-blind, double-dummy, parallel control of positive drug, multicenter clinical trial. Trials. 2019 Jul 19;20(1):446. doi: 10.1186/s13063-019-3539-5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Levofloxacin	Small molecule	0.1 g	Oral
Subject	Sanjin tablets	Traditional medicine (herbal / TCM)	3 unknown	—

Indications